Thyroid disease

DoD Funds Clarkson University Professors' Projects to Remove Toxic Chemicals From Water

Retrieved on: 
Wednesday, March 9, 2022
Molecule, Kidney, University, PFAS, Defense, Department, Partnership, Research, Groundwater, Science Publishing Group, Biophysical environment, University of California, Riverside, Catalysis, Thyroid disease, DOE, Undiluted, Complicated, Plasma, GLOBE, AFFF, Programmer, Blood, Clarkson University, Salt, Water, Environment, EPA, Assistant, Animal, Renewable energy, Environmental remediation

Potsdam, NY, March 09, 2022 (GLOBE NEWSWIRE) -- The Department of Defense Strategic Environmental Research and Development Program (SERDP) has awarded funding to the projects of three Clarkson University professors.

Key Points: 
  • Potsdam, NY, March 09, 2022 (GLOBE NEWSWIRE) -- The Department of Defense Strategic Environmental Research and Development Program (SERDP) has awarded funding to the projects of three Clarkson University professors.
  • PFAS are a group of chemicals that have been widely used for decades.
  • As additives in numerous consumer products, they have many desirable properties, including exceptional chemical resistance.
  • However, this property makes it very difficult to remove them from water using current treatment processes.

Clean Futures Fund Forced to Suspend Humanitarian Operations at Chernobyl Nuclear Power Plant Due to Russian Invasion of Ukraine and Capture of the Facility

Retrieved on: 
Friday, February 25, 2022
Accident, Future Fund, Thyroid disease, Diabetes, Chernobyl Nuclear Power Plant, Awareness, Chernobyl Exclusion Zone, Cat, Chernobyl New Safe Confinement, Fund, Dog, Food, Seizure, Russia, Uranium, Chernobyl

ST. LOUIS, Feb. 25, 2022 /PRNewswire/ -- Clean Futures Fund learned yesterday that the Chernobyl Nuclear Power Plant has been seized by Russian Federation forces as part of their unprovoked invasion of Ukraine.

Key Points: 
  • ST. LOUIS, Feb. 25, 2022 /PRNewswire/ -- Clean Futures Fund learned yesterday that the Chernobyl Nuclear Power Plant has been seized by Russian Federation forces as part of their unprovoked invasion of Ukraine.
  • Approximately 50 power plant workers and a crew of the Chernobyl Fire Brigade are trapped at the plant without Ukrainian protection and are unable to leave.
  • The seizure of the Chernobyl Nuclear Power Plant is a strategic asset.
  • We are currently focusing our efforts on the Chernobyl Nuclear Power Plant in Ukraine, the site of the world's largest nuclear disaster.

Eurofins’ empowerDX launches PFAS Exposure™ in the U.S, the First At-Home Blood Test to Detect and Measure 40+ PFAS Compounds

Retrieved on: 
Friday, January 21, 2022
FDA, Health, Infectious Diseases, Clinical Trials, Pharmaceutical, Biotechnology, CDC, NHANES, Respiratory disease, Research, PFAS, Fertility, Life, Collection, Thyroid disease, View, PFOS, Environment, Work, Serum, PFOA, Cancer, Blood, Laboratory, National Health and Nutrition Examination Survey, Eurofins Scientific

Today, Eurofins (Paris:ERF) subsidiary empowerDX has launched PFAS Exposure in the United States, the first direct to consumer at-home test to determine levels of PFAS in a persons blood and measure 47 of the PFAS forever chemical compounds.

Key Points: 
  • Today, Eurofins (Paris:ERF) subsidiary empowerDX has launched PFAS Exposure in the United States, the first direct to consumer at-home test to determine levels of PFAS in a persons blood and measure 47 of the PFAS forever chemical compounds.
  • One report by the CDCs National Health and Nutrition Examination Survey (NHANES) found PFAS in the blood of 97% of Americans.
  • To date, testing for PFAS in blood has relied on serum as an estimation for whole blood and required a blood draw conducted by a healthcare practitioner.
  • The PFAS Exposure kit is available in the United States through Eurofins at-home health testing business, empowerDX.

Toxin Free USA Sues CoverGirl for Cosmetic Products Containing Toxic PFAS

Retrieved on: 
Tuesday, December 28, 2021
Technology, Coty Inc., Congress, PFOA, Food packaging, Environmental science, Lip, Cancer, Multimedia, Environment, Skin, Environmental Science & Technology, GenX, 501(c)(3) organization, Immunity, Education, CoverGirl, PFOS, Birth, View, Autoimmune disease, Genetically modified organism, Thyroid disease, Clothing, Safety, Liver, Obesity, Time, Fertility, Coty, PFAS, Marketing, Lipstick, Cosmetics

WASHINGTON, Dec. 28, 2021 /PRNewswire/ -- Toxin Free USA, a national public-interest nonprofit dedicated to consumer protection and education, filed a first-of-its-kind false advertising lawsuit against CoverGirl Cosmetics and Coty Inc. for environmental and product safety misrepresentations due to indicators of toxic PFAS chemicals found in their products.

Key Points: 
  • WASHINGTON, Dec. 28, 2021 /PRNewswire/ -- Toxin Free USA, a national public-interest nonprofit dedicated to consumer protection and education, filed a first-of-its-kind false advertising lawsuit against CoverGirl Cosmetics and Coty Inc. for environmental and product safety misrepresentations due to indicators of toxic PFAS chemicals found in their products.
  • Toxin Free USA believes that consumers are being misled as products containing toxic PFAS chemicals are neither sustainable nor safe.
  • PFAS - perfluoroalkyl and polyfluoroalkyl substances - are a class of over 8,000 man-made chemicals, and include PFOA, PFOS, and GenX.
  • Toxin Free USA executive director, Diana Reeves, said, "Based on the level of organic fluorine detected in our investigation, a worrying level of PFAS is likely present in CoverGirl pressed powder.

New Study Confirms That A Commonly Used Acid-Reducing Drug Does Not Interfere with the Absorption of A Novel Liquid Levothyroxine Formulation

Retrieved on: 
Monday, October 4, 2021
Drug, Tablet, Hypothyroidism, Degenerative disease, Patient, Thyroid, Fatigue, Hair loss, Glycerol, Health, Water, FDA, Depression, GJ, Omeprazole, Constipation, Annual general meeting, Population, TSH, FT4, Thyroid disease, PPI, THE, Virginia Commonwealth University, University, Program, Arch, Internal medicine, Woman, Plasma protein binding, Medicine, Stomach, Absorption, ATA, Forgetting, Weight gain, Health care, Mouth, Cramp, American Thyroid Association, FT3, University of Pisa, IBSA, Pharmaceutical industry

Omeprazole and other PPI medications are powerful acid-reducing agents that are known to affect the performance of traditional levothyroxine treatments that come in tablet form.

Key Points: 
  • Omeprazole and other PPI medications are powerful acid-reducing agents that are known to affect the performance of traditional levothyroxine treatments that come in tablet form.
  • A second group was administered Tirosint-SOL and omeprazole at staggered times Tirosint-SOL in the morning and omeprazole in the evening, 12 hours later.
  • Based on these findings, IBSA Institut Biochimique, the sponsor of the study, is planning to seek FDA approval for a change in the approved label for Tirosint-SOL.
  • 46
    4.Canaris GJ, Manowitz NR, Mayor G, Ridgeway EC, "The Colorado Thyroid Disease Prevalence Study", Arch of Internal Medicine; 2000;160: 526-534
    5.McDermott MT.

Endocrine Cancer Expert Named Associate Chief of Surgery at NYU Langone Hospital--Brooklyn

Retrieved on: 
Thursday, August 12, 2021
Yale New Haven Hospital, Thyroid cancer, NYU Langone Health, Johns Hopkins Hospital, Thyroid disease, Air pollution, Doctor of Philosophy, Science, University, Parathyroidectomy, Program, Department, Research, General surgery, University of Colorado School of Medicine, Exocrine gland, Patient, Particulates, Johns Hopkins School of Medicine, NYU, Incidence, Endocrine disease, Education, Johns Hopkins, Therapy, Pharmaceutical industry, Dentistry, Medicine

NEW YORK, Aug. 12, 2021 /PRNewswire/ --Nationally renowned endocrine cancer expert Jason D. Prescott, MD, PhD , has been named associate chief of surgery for research and academic affairs at NYU Langone HospitalBrooklyn.

Key Points: 
  • NEW YORK, Aug. 12, 2021 /PRNewswire/ --Nationally renowned endocrine cancer expert Jason D. Prescott, MD, PhD , has been named associate chief of surgery for research and academic affairs at NYU Langone HospitalBrooklyn.
  • In addition to his clinical work, Dr. Prescott will oversee and expand clinical research projects that will elevate NYU Langone HospitalBrooklyn in areas of therapeutics, academics, and teaching.
  • He also will establish new patient clinics at NYU Langone HospitalBrooklyn and will have surgical privileges in Brooklyn and at NYU Langone's Tisch Hospital and Kimmel Pavilion.
  • While at Johns Hopkins Medical Center, Dr. Prescott served as chief of endocrine surgery,performing between 350 and 400 surgeries annually.

Anesthesia Disposables Global Market Report 2021 Featuring Ambu A/S, Medline Industries, Smiths Medical, Teleflex and Vyaire Medical - ResearchAndMarkets.com

Retrieved on: 
Friday, August 6, 2021
Pharmaceutical, Health, Medical Supplies, KSR International Co. v. Teleflex Inc., Arthritis, Respiratory disease, Nurse anesthetist, Prevalence, Press Uncuffed, Population, COVID-19, Pediatrics, Patient, Tidal volume, Airway management, Oxygen, Heat and moisture exchanger, Anesthesiology, Cardiovascular disease, Pain, Respiratory arrest, Ageing, HME, ETT, Child, Thyroid disease, Dentistry

The "Anesthesia Disposables Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Anesthesia Disposables Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the anesthesia disposables market are Ambu A/S (Denmark), Medline Industries, Inc. (USA), Smiths Medical, (USA), Teleflex, Inc. (USA) and Vyaire Medical Inc. (USA).
  • The anesthesia disposables market consists of sales of anesthesia disposables and related services.
  • These disposables include onetime use anesthesia circuits, anesthesia masks, sample lines, filters/Heat & Moisture Exchangers (HMEs), breathing bag, endotracheal tubes, and laryngeal masks.

Graves' Disease Market Insight, Epidemiology and Market Research Report 2021-2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021
Genetics, Pharmaceutical, Health, Articles, Medicine, Medical terminology, Thyroid disease, Actuarial science, Disease, Graves' disease, Epidemiology, Academic disciplines

The "Graves' Disease - Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Graves' Disease - Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's offering.
  • The Graves' Disease market report provides current treatment practices, emerging drugs, Graves' Disease market share of the individual therapies, current and forecasted Graves' Disease market Size from 2018 to 2030 segmented by seven major markets.
  • The Report also covers current Graves' Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
  • The Graves' Disease epidemiology division provide insights about historical and current Graves' Disease patient pool and forecasted trend for every seven major countries.

Global Graves Ophthalmopathy Market to 2030 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 22, 2021
Health, Optical, Thyroid disease, Autoimmune diseases, Anatomy, Thyroid, Organ systems, Graves' ophthalmopathy, Organs anatomy), TED

The "Graves Ophthalmopathy - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Graves Ophthalmopathy - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The Graves Ophthalmopathy market report provides current treatment practices, emerging drugs, Graves Ophthalmopathy market share of the individual therapies, current and forecasted Graves Ophthalmopathy market Size from 2017 to 2030 segmented by seven major markets.
  • The Graves Ophthalmopathy market report gives a thorough understanding of the Graves Ophthalmopathy by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.
  • The Graves Ophthalmopathy epidemiology division provide insights about historical and current Graves Ophthalmopathy patient pool and forecasted trend for every seven major countries.

Worldwide Disease Industry to 2026 - by Diagnosis, Treatment and Region - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 6, 2021
Health, Pharmaceutical, Anatomy, Thyroid disease, Branches of biology, Autoimmune diseases, Medicine, Medical terminology, Graves' disease, Disease, Thyroid

The global graves' disease market is growing at a CAGR of 4.2% during the forecast period.

Key Points: 
  • The global graves' disease market is growing at a CAGR of 4.2% during the forecast period.
  • The growing prevalence of auto-immune disorders such as thyroid disorder has created the demand for its treatment which in turn is driving the graves' disease market.
  • Advancement in treatment technology for effective treatment of graves' disease is one of the prime factors to drive the market growth.
  • Reimbursements offered by many governments and private insurance companies for Grave's disease diagnosis and treatment are furthermore augmenting the growth of Grave's disease market.